B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

LOXL3

MOLECULAR TARGET

lysyl oxidase like 3

UniProt: P58215NCBI Gene: 846953 compounds

LOXL3 (lysyl oxidase like 3) is targeted by 3 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).

Compounds Targeting LOXL3

Ranked by bioassay confidence score (PubChem active assay count × evidence quality).

#CompoundConfidenceActive Assays
1thiram2.4811
2pyrithione1.795
3Disulfiram0.691

About LOXL3 as a Drug Target

LOXL3 (lysyl oxidase like 3) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 3 compounds with documented LOXL3 interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.

LOXL3 inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.